BIT — Biotron Cashflow Statement
0.000.00%
- AU$5.41m
- AU$4.54m
- AU$1.65m
Annual cashflow statement for Biotron, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | -2.44 | -3.49 | -2.62 | -2.95 | -3.55 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | -3.08 | -3.41 | -2.44 | -3.29 | -3.57 |
Capital Expenditures | 0 | -0.006 | 0 | 0 | 0 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0 | — | — | — | — |
Other Investing Cash Flow | |||||
Cash from Investing Activities | 0 | -0.006 | 0 | 0 | 0 |
Financing Cash Flow Items | -0.275 | 0 | — | -0.428 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 5 | -0.037 | -0.033 | 5.53 | -0.023 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 1.92 | -3.45 | -2.47 | 2.24 | -3.59 |